These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 23396730)
21. IL28B polymorphisms, IP-10 and viral load predict virological response to therapy in chronic hepatitis C. Fattovich G; Covolo L; Bibert S; Askarieh G; Lagging M; Clément S; Malerba G; Pasino M; Guido M; Puoti M; Gaeta GB; Santantonio T; Raimondo G; Bruno R; Bochud PY; Donato F; Negro F; Aliment Pharmacol Ther; 2011 May; 33(10):1162-72. PubMed ID: 21443535 [TBL] [Abstract][Full Text] [Related]
22. Handgrip Strength and Vitamin D as Predictors of Liver Fibrosis and Malnutrition in Chronic Hepatitis C Patients. Gabr SA; Alghadir AH Dis Markers; 2021; 2021():6665893. PubMed ID: 33884041 [TBL] [Abstract][Full Text] [Related]
23. Association between CXCL10 and DPP4 Gene Polymorphisms and a Complementary Role for Unfavorable IL28B Genotype in Prediction of Treatment Response in Thai Patients with Chronic Hepatitis C Virus Infection. Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P PLoS One; 2015; 10(9):e0137365. PubMed ID: 26339796 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of vitamin D deficiency in chronic liver disease. Arteh J; Narra S; Nair S Dig Dis Sci; 2010 Sep; 55(9):2624-8. PubMed ID: 19960254 [TBL] [Abstract][Full Text] [Related]
26. The relation of 25-hydroxy vitamin D concentrations to liver histopathology, seasonality and baseline characteristics in chronic hepatitis C virus genotype 2 or 3 infection. Waldenström J; Nyström K; Nilsson S; Norkrans G; Ydreborg M; Langeland N; Mørch K; Westin J; Lagging M PLoS One; 2020; 15(8):e0237840. PubMed ID: 32822420 [TBL] [Abstract][Full Text] [Related]
27. Hypovitaminosis D and its relation to demographic and laboratory data among hepatitis C patients. Melo-Villar L; Lampe E; de Almeida AJ; de P Scalioni L; Lewis-Ximenez LL; Miguel JC; Del Campo JA; Ranchal I; Villela-Nogueira CA; Romero-Gomez M Ann Hepatol; 2015; 14(4):457-63. PubMed ID: 26019031 [TBL] [Abstract][Full Text] [Related]
28. Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C. Falleti E; Bitetto D; Fabris C; Fattovich G; Cussigh A; Cmet S; Ceriani E; Fornasiere E; Pasino M; Ieluzzi D; Pirisi M; Toniutto P Hepatology; 2012 Nov; 56(5):1641-50. PubMed ID: 22610885 [TBL] [Abstract][Full Text] [Related]
29. GC Gene Polymorphism and Unbound Serum Retinol-Binding Protein 4 Are Related to the Risk of Insulin Resistance in Patients With Chronic Hepatitis C: A Prospective Cross-Sectional Study. Mateos-Muñoz B; García-Martín E; Torrejón MJ; Devesa-Medina MJ; Esguevillas G; Cárdenas MC; Fernández C; Carballo M; Agúndez JA; Ladero JM Medicine (Baltimore); 2016 Mar; 95(10):e3019. PubMed ID: 26962819 [TBL] [Abstract][Full Text] [Related]
30. Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection. Kitson MT; Dore GJ; George J; Button P; McCaughan GW; Crawford DH; Sievert W; Weltman MD; Cheng WS; Roberts SK J Hepatol; 2013 Mar; 58(3):467-72. PubMed ID: 23183524 [TBL] [Abstract][Full Text] [Related]
31. Interleukin-28B single nucleotide polymorphism of donors and recipients can predict viral response to pegylated interferon/ribavirin therapy in patients with recurrent hepatitis C after living donor liver transplantation. Kawaoka T; Takahashi S; Takaki S; Hiramatsu A; Waki K; Hiraga N; Miki D; Tsuge M; Imamura M; Kawakami Y; Aikata H; Ochi H; Onoe T; Tashiro H; Ohdan H; Chayama K J Gastroenterol Hepatol; 2012 Sep; 27(9):1467-72. PubMed ID: 22432893 [TBL] [Abstract][Full Text] [Related]
32. Association between vitamin D and hepatitis C virus infection: a meta-analysis. Villar LM; Del Campo JA; Ranchal I; Lampe E; Romero-Gomez M World J Gastroenterol; 2013 Sep; 19(35):5917-24. PubMed ID: 24124339 [TBL] [Abstract][Full Text] [Related]
33. Both Hepatitis C Virus-Specific T Cell Responses and IL28B rs12979860 Single-Nucleotide Polymorphism Genotype Influence Antihepatitis C Virus Treatment Outcome in Patients with Chronic Hepatitis C. Benito JM; García-Samaniego J; García M; Madejón A; Martín-Carbonero L; Cabello A; Álvarez B; Górgolas M; Rallón N J Interferon Cytokine Res; 2017 Jun; 37(6):278-286. PubMed ID: 28440692 [TBL] [Abstract][Full Text] [Related]
34. Serum vitamin D₃ does not correlate with liver fibrosis in chronic hepatitis C. Ren Y; Liu M; Zhao J; Ren F; Chen Y; Li JF; Zhang JY; Qu F; Zhang JL; Duan ZP; Zheng SJ World J Gastroenterol; 2015 Oct; 21(39):11152-9. PubMed ID: 26494969 [TBL] [Abstract][Full Text] [Related]
35. Influence of hepatitis C virus and IL28B genotypes on liver stiffness. Lundbo LF; Clausen LN; Weis N; Schønning K; Rosenørn L; Benfield T; Christensen PB PLoS One; 2014; 9(12):e115882. PubMed ID: 25545640 [TBL] [Abstract][Full Text] [Related]
36. Effects of IL28B rs12979860 CC genotype on metabolic profile and sustained virologic response in patients with genotype 1 chronic hepatitis C. Petta S; Rosso C; Leung R; Abate ML; Booth D; Salomone F; Gambino R; Rizzetto M; Caviglia P; Smedile A; Grimaudo S; Cammà C; Craxì A; George J; Bugianesi E Clin Gastroenterol Hepatol; 2013 Mar; 11(3):311-7.e1. PubMed ID: 23220171 [TBL] [Abstract][Full Text] [Related]
37. Influence of interleukin-28B single-nucleotide polymorphisms on progression to liver cirrhosis in human immunodeficiency virus-hepatitis C virus-coinfected patients receiving antiretroviral therapy. Barreiro P; Pineda JA; Rallón N; Naggie S; Martín-Carbonero L; Neukam K; Rivero A; Benito JM; Caruz A; Vispo E; Camacho A; Medrano J; McHutchison J; Soriano V J Infect Dis; 2011 Jun; 203(11):1629-36. PubMed ID: 21592993 [TBL] [Abstract][Full Text] [Related]
38. The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients. Baur K; Mertens JC; Schmitt J; Iwata R; Stieger B; Frei P; Seifert B; Bischoff Ferrari HA; von Eckardstein A; Müllhaupt B; Geier A; Antivir Ther; 2012; 17(3):541-7. PubMed ID: 22300961 [TBL] [Abstract][Full Text] [Related]
39. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review. Hoan NX; Tong HV; Song LH; Meyer CG; Velavan TP World J Gastroenterol; 2018 Jan; 24(4):445-460. PubMed ID: 29398866 [TBL] [Abstract][Full Text] [Related]
40. Vitamin D deficiency is associated with severity of liver disease in HIV/HCV coinfected patients. Guzmán-Fulgencio M; García-Álvarez M; Berenguer J; Jiménez-Sousa MÁ; Cosín J; Pineda-Tenor D; Carrero A; Aldámiz T; Alvarez E; López JC; Resino S J Infect; 2014 Feb; 68(2):176-84. PubMed ID: 24184809 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]